Morgan Stanley's wealth management arm will pay a multi million-dollar after allegedly failing to stop four former financial ...

VanEck predicts strong crypto growth in 2025, with Bitcoin reaching $180,000 and Ethereum surpassing $6,000. The firm expects ...

A five-day runup in Treasury yields finally tamped down the post-election fervour in big US stocks last week. Not so at the ...

Edwards Lifesciences Corp (EW) stock saw a decline, ending the day at $73.32 which represents a decrease of $-0.65 or -0.88% from the prior close of $73.97. The stock opened at $73.91 and touched a ...

Morgan Stanley analyst Ravi Shanker raised the firm’s price target on C.H. Robinson (CHRW) to $70 from $65 but keeps an ...

Wall Street investors love growth, and ServiceTitan offers the potential for plenty of it. The company's revenue in the 12 months that ended July 31 rose 24% to $685 million. But ServiceTitan sees ...

Morgan Stanley has recently raised Cloudflare Inc (NET) stock rating, as announced on December 2, 2024, according to Finviz. Earlier, on October 8, 2024, Exane BNP Paribas had initiated the stock to ...

Call it the Trump effect. Tesla stock is up over 73% since Trump’s election win last month. CEO Elon Musk’s big bet on a ...

Import prices edged up 0.1% last month after a downwardly revised 0.1% rise in October, the Labor Department's Bureau of ...

Morgan Stanley has upgraded PTC Therapeutics (PTCT), while downgrading Immuneering (IMRX) and Amicus Therapeutics (FOLD).

Sempra (NYSE:SRE) +1.5% in Friday's trading as Morgan Stanley upgrades to Overweight from Equal Weight with a $98 price target, raised from $85, seeing strong growth potential in Texas given that the ...

Border cities like San Diego have obvious concerns about the impact of a trade war, but the ripples would extend into the South and Midwest, analysts say.